2cureX AB expands its Board of Directors with Michael Lutz and Nils Brünner
Michael Lutz and Nils Brünner have been elected to the Board of Directors in connection with the Extraordinary General Meeting on July 2, 2020. Michael Lutz and Nils Brünner will bring important complementary competencies and international experiences to the 2cureX Board at a landmark moment of launching indiTreat®. At the same time Timm Jessen, founding partner of 2cureX has announced that he will step down from the Board for personal reasons. Inlägget 2cureX AB expands its Board of Directors with Michael Lutz and Nils Brünner dök först upp på IPO.
se.